NVG The Navigator Company, S.A.
The Navigator Company, S.A. engages in the production of forestry, pulp, paper, tissue, and packaging solutions worldwide. The company operates through Market Folder, UWF Paper, Tissue Paper, and Energy segments. It is involved in the production of pulp, printing, and writing papers under the Navigator, Pioneer, and Inacopia brands; production of tissue under the Amoos brand; provision of packaging solutions under the gKraft brand; research, acquisition, and sale of wood; production of bleached eucalyptus pulp; and production and commercialization of thermal and electrical energy. The company was formerly known as Portucel, S.A. and changed its name to The Navigator Company, S.A. in February 2016. The company was founded in 1953 and is headquartered in Setúbal, Portugal. The Navigator Company, S.A. operates as a subsidiary of Semapa - Sociedade de Investimento e Gestão, SGPS, S.A.…
Industry Peers
Paper & Paper ProductsKey Statistics
About The Navigator Company (ELI: NVG)
›
The Navigator Company (ELI: NVG) is listed on Euronext Lisbon, where its shares trade in EUR. It belongs to the Paper & Paper Products industry, part of the Basic Materials sector, and reports about 3,932 employees.
The shares were at 2.964 EUR on 19 November 2026, roughly unchanged over 52 weeks. Its 52-week range is 2.888 EUR to 3.590 EUR: the price is 17.4% below the high and 2.6% above the low.
At a market capitalisation of 2.11B EUR, it trades at 22.8 times trailing earnings and 10.9 times forward earnings. The median trailing P/E of its 15 largest Paper & Paper Products peers is 21.0, so NVG is valued in line with them. It pays a dividend yielding 3.70% (it pays out 87% of its earnings), against a median of 3.25% among the dividend payers in that peer group.
The Navigator Company reports return on equity of 10.2%, an operating margin of 6.0% and revenue down 3.1% year over year.
Its debt exceeds its cash by 900.02M EUR, a debt-to-equity ratio of 0.68. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 4 analysts cover the stock, with an average rating of Buy; their mean price target of 3.675 EUR is 24.0% above the current price. The next earnings report is expected on 18 February 2027.